A client with osteoporosis has been prescribed alendronate. Which statement reflects accurate education for the client regarding this medication?

Introduction: Osteoporosis is a skeletal disorder characterized by compromised bone strength and increased fracture risk. Alendronate, a bisphosphonate, inhibits osteoclast-mediated bone resorption; however, it possesses extremely poor oral bioavailability and carries a significant risk for causing severe esophageal irritation and chemical ulceration if improperly administered. A. Alendronate must be taken at least 30 minutes before the first food, beverage, or medication of the day. Using a full glass of PLAIN WATER is essential to facilitate the rapid transit of the tablet into the stomach, thereby maximizing the limited absorption window and minimizing the duration of contact with the esophageal mucosa. B. Taking this medication right before bed is strictly contraindicated. The patient must remain in an upright position for at least 30 minutes following administration to prevent ESOPHAGEAL REFLUX. Recumbency shortly after ingestion increases the risk of the medication remaining in the esophagus, which can lead to severe erosive esophagitis or perforation. C. This statement is pharmacologically incorrect. The absorption of bisphosphonates is significantly reduced—often to negligible levels—by the presence of food, minerals, or caffeine in the stomach. To achieve therapeutic serum levels, the drug must be administered in a fasting state to prevent interference from dietary cations like calcium. D. Lying down immediately after dose administration is a dangerous practice for patients on alendronate. Post-dose UPRIGHT POSTURE is a mandatory safety requirement to ensure gravity assists the passage of the medication through the diaphragm and into the gastric environment, protecting the sensitive squamous epithelium of the esophagus from chemical burns.